| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TEXAS INSTRUMENTS INC | Director | Common Stock | 37.1K | $7.54M | $203.33 | Jan 27, 2025 | Direct |
| CARDINAL HEALTH INC | Director | Common Shares | 41.6K | $4.46M | $107.08 | Nov 9, 2022 | Direct |
| Organon & Co. | Executive Chair, Director | Phantom Stock | 74K | $743K | $10.04 | Jun 13, 2025 | Direct |
| Solventum Corp | Director | Restricted Stock Units | 0 | $736K | $64.11 | May 13, 2025 | Direct |
| Organon & Co. | Executive Chair, Director | Common Stock | 77.9K | $597K | $7.67 | Nov 12, 2025 | IRA |
| TEXAS INSTRUMENTS INC | Director | NQ Stock Option (Right to Buy) | 2.55K | $444K | $174.10 | Jan 27, 2025 | Direct |
| Solventum Corp | Director | Common Stock | 5.15K | $336K | $65.32 | May 13, 2025 | Direct |
| Cartesian Therapeutics, Inc. | Director | Common Stock | 15.6K | $51.6K | $3.30 | Jan 2, 2025 | Direct |
| Cartesian Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 8K | $6.32K | $0.79 | Jan 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OGN | Organon & Co. | Nov 12, 2025 | 1 | $502K | 4 | Nov 13, 2025 | Executive Chair, Director |
| OGN | Organon & Co. | Jun 13, 2025 | 1 | $240K | 4 | Jun 16, 2025 | Director |
| OGN | Organon & Co. | May 14, 2025 | 1 | $101K | 4 | May 15, 2025 | Director |
| SOLV | Solventum Corp | May 13, 2025 | 2 | $0 | 4 | May 15, 2025 | Director |
| SOLV | Solventum Corp | Apr 30, 2025 | 1 | $0 | 4 | May 2, 2025 | Director |
| TXN | TEXAS INSTRUMENTS INC | Jan 27, 2025 | 2 | $0 | 4 | Jan 29, 2025 | Director |
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Director |
| OGN | Organon & Co. | Jun 7, 2024 | 1 | $200K | 4 | Jun 11, 2024 | Director |
| SOLV | Solventum Corp | May 13, 2024 | 2 | $0 | 4 | May 15, 2024 | Director |
| SOLV | Solventum Corp | Apr 1, 2024 | 0 | $0 | 3 | Apr 2, 2024 | Director |
| TXN | TEXAS INSTRUMENTS INC | Jan 25, 2024 | 2 | $0 | 4 | Jan 29, 2024 | Director |
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director |
| SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 5 | -$115K | 4 | Nov 15, 2023 | Director |
| TXN | TEXAS INSTRUMENTS INC | Jul 31, 2023 | 5 | -$1.88M | 4 | Aug 3, 2023 | Director |
| OGN | Organon & Co. | Jun 9, 2023 | 1 | $200K | 4 | Jun 13, 2023 | Director |
| TXN | TEXAS INSTRUMENTS INC | Jan 26, 2023 | 2 | $0 | 4 | Jan 30, 2023 | Director |
| SELB | SELECTA BIOSCIENCES INC | Jan 2, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| CAH | CARDINAL HEALTH INC | Nov 9, 2022 | 1 | $0 | 4 | Nov 10, 2022 | Director |
| SELB | SELECTA BIOSCIENCES INC | Jun 13, 2022 | 1 | $150K | 4 | Jun 15, 2022 | Director |
| OGN | Organon & Co. | Jun 10, 2022 | 1 | $200K | 4 | Jun 14, 2022 | Director |
| TXN | TEXAS INSTRUMENTS INC | Jan 27, 2022 | 2 | $0 | 4 | Jan 31, 2022 | Director |
| SELB | SELECTA BIOSCIENCES INC | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| SELB | SELECTA BIOSCIENCES INC | Dec 3, 2021 | 1 | $50.7K | 4 | Dec 6, 2021 | Director |
| CAH | CARDINAL HEALTH INC | Nov 11, 2021 | 1 | $0 | 4 | Nov 15, 2021 | Director |
| OGN | Organon & Co. | Jun 4, 2021 | 1 | $652K | 4 | Jun 8, 2021 | Director |
| OGN | Organon & Co. | Jun 2, 2021 | 0 | $0 | 3 | Jun 2, 2021 | Director |